Driehaus Capital Management LLC Essa Pharma Inc. Transaction History

Driehaus Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.6 - $3.34 $614,304 - $789,145	-236,271 Reduced 89.3%	28,300 $76,000
Q4 2022 Feb 14, 2023	BUY	$1.5 - $4.82 $396,856 - $1.28 Million	264,571 New	264,571 $666,000
Q3 2021 Nov 15, 2021	SELL	$7.76 - $29.37 $2.7 Million - $10.2 Million	-348,524 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$24.17 - $34.28 $4.9 Million - $6.95 Million	-202,598 Reduced 36.76%	348,524 $9.96 Million
Q1 2021 May 17, 2021	SELL	$11.61 - $32.08 $5.77 Million - $16 Million	-497,402 Reduced 47.44%	551,122 $16 Million
Q4 2020 Feb 16, 2021	BUY	$5.47 - $12.1 $3.66 Million - $8.09 Million	668,524 Added 175.93%	1,048,524 $12.5 Million
Q3 2020 Nov 16, 2020	BUY	$6.0 - $7.79 $2.28 Million - $2.96 Million	380,000 New	380,000 $2.62 Million

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $77.1M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.